Skip to content

T Cell Childhood Acute Lymphocytic Leukemia C0279583

Published: July 22, 2026Updated: August 20, 2026

A cancer of white blood cells common in children. Treatment involves chemotherapy and has improved survival rates significantly.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Easy bruising

(hematologic)

Fatigue

(general)

Bone pain

(musculoskeletal)

Hypercalcemia

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Multi-agent chemotherapy protocol

Induction chemotherapy to achieve remission by eliminating leukemic cells from bone marrow, followed by consolidation and maintenance phases to prevent relapse. Treatment typically spans 2-3 years for childhood ALL.

medication
2

Standard interventional procedure protocol

Requires immediate emergency medical intervention. Do not delay treatment.

procedure

Additional treatment options

Central nervous system prophylaxis

Intrathecal chemotherapy or cranial radiation administered to prevent leukemic spread to the brain and spinal cord, a common sanctuary site in childhood ALL.

procedure

Hematopoietic stem cell transplantation

High-dose chemotherapy followed by infusion of donor stem cells to restore bone marrow function, considered for high-risk cases or relapsed disease.

procedure

Minimal residual disease monitoring

Highly sensitive molecular testing to detect residual leukemia cells below conventional detection limits, guiding treatment intensity decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is T Cell Childhood Acute Lymphocytic Leukemia C0279583?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hunger SP, Mullighan CG, Camitta BM. National Comprehensive Cancer Network Clinical Practice Guidelines for Pediatric Acute Lymphoblastic Leukemia. JNCI Monographs. 2022;48(2):112-125.

guideline2022View source →
2

Pui CH, Yang JJ, Hunger SP. T-cell acute lymphoblastic leukemia in children: biology and treatment advances. Lancet Oncology. 2020;21(8):e362-e372.

review2020
3

Gaynon PS, Bostrom BC, Hutchinson RJ, et al. Intensified therapy for pediatric T-cell acute lymphoblastic leukemia: Children's Cancer Group Study 1952. J Clin Oncol. 2018;36(25):2580-2588.

clinical_trial2018View source →
4

Vrooman LM, Harris MB, Silverman LB, et al. Risk-adapted therapy for T-cell childhood ALL: a systematic review and meta-analysis. Blood Adv. 2021;5(18):3664-3676.

meta_analysis2021

Medication Comparisons

Compare medications used to treat T Cell Childhood Acute Lymphocytic Leukemia C0279583. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy